108 related articles for article (PubMed ID: 28857155)
1. Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
Fountzilas G; Psyrri A; Giannoulatou E; Tikas I; Manousou K; Rontogianni D; Ciuleanu E; Ciuleanu T; Resiga L; Zaramboukas T; Papadopoulou K; Bobos M; Chrisafi S; Tsolaki E; Markou K; Giotakis E; Koutras A; Psoma E; Kalogera-Fountzila A; Skondra M; Bamia C; Pectasides D; Kotoula V
Int J Cancer; 2018 Jan; 142(1):66-80. PubMed ID: 28857155
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
[TBL] [Abstract][Full Text] [Related]
3. Expression of BRCA1 and ERCC1 as predictive clinical outcome after radiochemotherapy in patients with locoregionally moderate-advanced nasopharyngeal carcinoma.
Xu S; Yu Y; Rong J; Hu D; Zhang L; Fu S; Yang H; Fan J; Yang L; Wu J
Oncotarget; 2017 May; 8(19):31355-31367. PubMed ID: 28404895
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg JA; Braunius WW; Zuur CI; Koljenović S; Willems SM
Oral Oncol; 2017 Aug; 71():16-25. PubMed ID: 28688685
[TBL] [Abstract][Full Text] [Related]
5. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
Strickland KC; Howitt BE; Shukla SA; Rodig S; Ritterhouse LL; Liu JF; Garber JE; Chowdhury D; Wu CJ; D'Andrea AD; Matulonis UA; Konstantinopoulos PA
Oncotarget; 2016 Mar; 7(12):13587-98. PubMed ID: 26871470
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients.
Kotoula V; Lakis S; Tikas I; Giannoulatou E; Lazaridis G; Papadopoulou K; Manoussou K; Efstratiou I; Papanikolaou A; Fostira F; Vlachos I; Tarlatzis B; Fountzilas G
Gynecol Oncol; 2019 Feb; 152(2):375-386. PubMed ID: 30446274
[TBL] [Abstract][Full Text] [Related]
7. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes.
Zhang L; MacIsaac KD; Zhou T; Huang PY; Xin C; Dobson JR; Yu K; Chiang DY; Fan Y; Pelletier M; Wang Y; Jaeger S; Krishnamurthy Radhakrishnan V; JeBailey L; Skewes-Cox P; Zhang J; Fang W; Huang Y; Zhao H; Zhao Y; Li E; Peng B; Huang A; Dranoff G; Hammerman PS; Engelman J; Bitter H; Zeng YX; Yao Y
Mol Cancer Res; 2017 Dec; 15(12):1722-1732. PubMed ID: 28851814
[TBL] [Abstract][Full Text] [Related]
8. Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway.
Chung AK; OuYang CN; Liu H; Chao M; Luo JD; Lee CY; Lu YJ; Chung IC; Chen LC; Wu SM; Tsang NM; Chang KP; Hsu CL; Li HP; Chang YS
Cancer Med; 2019 Sep; 8(11):5116-5127. PubMed ID: 31328403
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal homogeneity and distinctness of the T-cell receptor β-chain repertoires in Epstein-Barr virus-associated primary and metastatic nasopharyngeal carcinomas.
Chung YL; Wu ML
Int J Cancer; 2018 Aug; 143(3):610-620. PubMed ID: 29468660
[TBL] [Abstract][Full Text] [Related]
11. Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
Liu Y; Yasukawa M; Chen K; Hu L; Broaddus RR; Ding L; Mardis ER; Spellman P; Levine DA; Mills GB; Shmulevich I; Sood AK; Zhang W
JAMA Oncol; 2015 Jul; 1(4):486-94. PubMed ID: 26181259
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of excision repair cross- complementation group 1 expression in locoregionally advanced nasopharyngeal carcinoma receiving cisplatin-based concurrent chemoradiotherapy.
Wang D; Zhou J; Zheng J; Zhang J; Chen Y; Li W; Wang R
Cancer Biomark; 2018; 21(4):875-881. PubMed ID: 29439312
[TBL] [Abstract][Full Text] [Related]
13. [Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas].
Chen HK; Liu XQ; Lin J; Chen TY; Feng QS; Zeng YX
Ai Zheng; 2002 Oct; 21(10):1047-50. PubMed ID: 12508640
[TBL] [Abstract][Full Text] [Related]
14. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
Škapa P; Dundr P
Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
[TBL] [Abstract][Full Text] [Related]
15. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
16. PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.
Wang MY; Lin ZR; Cao Y; Zheng LS; Peng LX; Sun R; Meng DF; Xie P; Yang JP; Cao L; Xu L; Huang BJ; Qian CN
Oncotarget; 2016 May; 7(18):26604-16. PubMed ID: 27049917
[TBL] [Abstract][Full Text] [Related]
17. BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.
Mafficini A; Simbolo M; Parisi A; Rusev B; Luchini C; Cataldo I; Piazzola E; Sperandio N; Turri G; Franchi M; Tortora G; Bovo C; Lawlor RT; Scarpa A
Oncotarget; 2016 Jan; 7(2):1076-83. PubMed ID: 26745875
[TBL] [Abstract][Full Text] [Related]
18. High expression of Zinc-finger protein X-linked is associated with reduced E-cadherin expression and unfavorable prognosis in nasopharyngeal carcinoma.
Li Y; Yan X; Yan L; Shan Z; Liu S; Chen X; Zou J; Zhang W; Jin Z
Int J Clin Exp Pathol; 2015; 8(4):3919-27. PubMed ID: 26097576
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma.
Dai W; Chung DL; Chow LK; Yu VZ; Lei LC; Leong MM; Chan CK; Ko JM; Lung ML
Clin Cancer Res; 2020 Dec; 26(24):6494-6504. PubMed ID: 32988965
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
